Dutasteride treatment and its effect on standardized uptake values in prostate-specific membrane antigen-PET imaging: A pilot study
Lucas Praetzel, Irene A Burger, Jan H Rüschoff, Niels J Rupp, Daniel Eberli, Benedikt Kranzbühler · 2026
Read Dutasteride treatment and its effect on standardized uptake values in prostate-specific membrane antigen-PET imaging: A pilot study by Lucas Praetzel, Irene A Burger, Jan H Rüschoff, Niels J Rupp, Daniel Eberli, Benedikt Kranzbühler (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0348695.txt.
Description
Lucas Praetzel and colleagues ran a small pilot study on a trick to make prostate cancer easier to see on scans. The scans rely on a protein called PSMA, which sits on prostate cells but is sometimes too scarce to detect. Earlier lab work suggested the drug dutasteride can raise PSMA levels. Four patients in this 2026 study took the drug for one week between two scans.
Signal strength rose in every patient after the drug course. Biopsies then confirmed cancer in the brightened spots, while one spot that faded proved cancer-free. With only four patients, the authors call the result a promising lead: a short drug course before scanning might catch tumours that would otherwise stay hidden.
Catalog record
| CREATOR | Lucas Praetzel, Irene A Burger, Jan H Rüschoff, Niels J Rupp, Daniel Eberli, Benedikt Kranzbühler |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26131 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |